Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2025-12-25 @ 10:16 PM
NCT ID:
NCT00730158
Group ID:
EG001
Title:
Arm B - Irinotecan + Placebo
Description:
Irinotecan: Irinotecan will be administered intravenously once every 2 weeks from the first cycle, at a dose of 215 mg/m².
Placebo: Placebo capsules will be administered orally twice a day for 4 days on days 1-4 every 2 weeks.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
4
Serious Number At Risk:
15
Other Number Affected:
10
Other Number At Risk:
15
Study:
NCT00730158
Results Section:
NCT00730158
Adverse Events Module:
NCT00730158